55 Scoping review pediatric patient engagement Supplement 2 - (continued) First author Year Country N Disease group Age (min) Age (max) Used method* Setting Roper [224] 2018 United Kingdom 16 Asthma 7 15 1 Clinical care Rosenberg [225] 2016 United States 18 Oncology 14 25 1 Clinical care Ruhe [226] 2016 Switzerland 17 Oncology 9 17 1 Clinical care Ruhe [227] 2016 Switzerland 17 Oncology 9 17 1 Clinical care Ruland [228] 2007 Norway 7 Oncology 8 12 1,2 Intervention development Runeson [229] 2000 Sweden 26 Multiple disease groups 6 17 1 Clinical care Sartain [230] 2000 United Kingdom 7 Multiple disease groups 8 14 1 Clinical care Sartain [231] 2001 United Kingdom 11 Hospital admission 5 12 1,3 Clinical care Savedra [232] 1988 United States 6 Multiple disease groups 13 16 1,4 Clinical care Schalkers [233] 2015 The Netherlands 63 Multiple disease groups 6 18 1,4,5,8 Clinical care Schmidt [234] 2007 United States 65 Multiple disease groups 5 18 1,7 Clinical care Schmidt [235] 2012 United States 20 Diabetes 8 15 1 Clinical care Schwellnus [236] 2020 Canada 10 Head / brain injury 6 19 1 Clinical care Sease [237] 2021 United States 2 Obesity 6 18 1 Clinical care Sepponen [238] 2003 Finland 31 Asthma 7 13 1 Clinical care Shaw [239] 2006 United Kingdom 28 Asthma NR NR 1 Clinical care Sherratt [240] 2018 United Kingdom 8 Juvenile Idiopathic Arthritis 8 16 1 Research Sjoberg [241] 2015 Sweden 10 Surgery 8 11 1 Clinical care Skolin [242] 2006 Sweden 22 Oncology 2 17 1 Clinical care Sleath [243] 2016 United States 18 Asthma 11 17 2 Intervention development Smeland [244] 2019 Norway 20 Surgery 8 16 1 Clinical care Smith [245] 2005 United Kingdom 9 Surgery 7 11 3 Clinical care Smith [246] 2019 United States 7 Oncology 7 17 2 Clinical care Squitieri [247] 2013 United States 18 Nerve damage 10 17 1 Clinical care Stegenga [248] 2013 United States 12 Sickle cell disease 6 14 1 Clinical care 2
RkJQdWJsaXNoZXIy MTk4NDMw